Cargando…
Evaluation of the benefit of addition of clidinium C to a Helicobacter pylori eradication regimen
AIM: This study aimed to evaluate the success of H.pylori eradication therapy in patients with dyspepsia by therapeutics regimes with and without clidinium C. BACKGROUND: Helicobacter pylori infections are reported in all parts of the world. Appropriate antibiotic therapy can treat infection. The id...
Autores principales: | Chorami, Maryam, Zojaji, Homayoun, Naderi, Nosratollah, Moghimi-Dehkordi, Bijan, Mirsattari, Dariush, Shalmani, Hamid Mohaghegh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Institute for Gastroenterology and Liver Diseases
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017509/ https://www.ncbi.nlm.nih.gov/pubmed/24834261 |
Ejemplares similares
-
Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease
por: Ehsani Ardakani, Mohammad Javad, et al.
Publicado: (2014) -
Addition of clidinium-C to the 14-day proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2016) -
The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: a randomized controlled trial
por: Zojaji, Homayoun, et al.
Publicado: (2013) -
The
Helicobacter pylori
eradication in the group receiving standard -dose and group continue taking amoxicillin for 4 weeks; a clinical trial study
por: Ehsani-Ardakani, Mohammad Javad, et al.
Publicado: (2015) -
Hybrid Therapy Regimen for Helicobacter Pylori Eradication
por: Song, Zhi-Qiang, et al.
Publicado: (2016)